HOME >> MEDICINE >> NEWS
Who's the liar? Brain MRI stands up to polygraph test

Traditional polygraph tests to determine whether someone is lying may take a back seat to functional magnetic resonance imaging (fMRI), according to a study appearing in the February issue of Radiology. Researchers from Temple University Hospital in Philadelphia used fMRI to show how specific areas of the brain light up when a person tells a lie.

"We have detected areas of the brain activated by deception and truth-telling by using a method that is verifiable against the current gold standard method of lie detection--the conventional polygraph," said lead author Feroze B. Mohamed, Ph.D., Associate Professor of Radiology at Temple.

Dr. Mohamed explained how the standard polygraph test has failed to produce consistently reliable results, largely because it relies on outward manifestations of certain emotions that people feel when lying. These manifestations, including increased perspiration, changing body positions and subtle facial expressions, while natural, can be suppressed by a large enough number of people that the accuracy and consistency of the polygraph results are compromised.

"Since brain activation is arguably less susceptible to being controlled by an individual, our research will hopefully eliminate the shortcomings of the conventional polygraph test and produce a new method of objective lie detection that can be used reliably in a courtroom or other setting," Dr. Mohamed said.

Dr. Mohamed and colleagues recruited 11 healthy subjects for the study. A mock shooting was staged, in which blank bullets were fired in a testing room. Five volunteers were asked to tell the truth when asked a series of questions about their involvement, and six were asked to deliberately lie. Each volunteer was examined with fMRI to observe brain activation while they answered questions either truthfully or deceptively. They also underwent a conventional polygraph test, where respiration, cardiovascular activity and perspiration responses were mon
'"/>

Contact: Heather Babiar
hbabiar@rsna.org
630-590-7762
Radiological Society of North America
31-Jan-2006


Page: 1 2

Related medicine news :

1. Whos vCJD case definition should be revised
2. Whos available to help in times of crisis and disaster?
3. Brain-boosting pill alleviates post-chemotherapy fogginess
4. Brain inflammation may be friend, not foe, for Alzheimers patients
5. Brain activity reflects differences in types of anxiety
6. Brain research poised to dramatically advance global society
7. Elsevier announces launch of Brain Stimulation
8. Brains scans of symptomatic Gulf War veterans show differences
9. Brain structure changes years before memory loss begins
10. Brain studies reveal the mechanisms of the voluntary control of visual attention
11. Brains can recover from alcoholic damage but patients should stop drinking as soon as possible

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Who the liar Brain MRI stands polygraph test

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: